Novelties in the field of fluoroquinolones

Bibliography

• BRYSKIER A: Recent advances in fluoroquinolone re-search. CUIT. Opin. Invest. Drugs (1993) 2:409–415.
   Google Scholar
• BRYSKIER A: Update on fluoroquinolones. Exp. Opin. Invest. Drugs (1994) 3:41–49.
   Google Scholar
• BRYSKIER A: New fluoroquinolones issued in 1994. Exp. Opin. Invest. Drugs (1995) 4:649–655.
   Google Scholar
• CHU DTW: The future role of quinolones. Exp. Opin. Ther. Patents (1996) 8:711–737.
   Google Scholar
• ALDRIDGE KE, ASHCRAFT D: BAY 12–8039, a new 8-methoxyquinolone: in vitro activity against clinically important anaerobes. 36th Interscience Conference on Antimicrobial Agents & Chemotherapy New Orleans (1996). F015.
   Google Scholar
• HAYASHI N, AMANO H, OHSHITA Y et al In vitro and in vivo activities, pharmacokinetics and toxicity of WQ 2756 and WQ 2765 two novel fluoroquinolones. 36th Intel-science Conference on Antimicrobial Agents & Chemo-therapy New Orleans (1996). F051.
   Google Scholar
• HAYASHI N, HIRAO Y, AMANO H et al.: WQ 0835 a prototypical tricyclic quinolone: in vitro and in vivo antibacterial activities and pharmacokinetics. 35th In-terscience Conference on Antimicrobial Agents & Chemother-apy San Francisco (1995). F192.
   Google Scholar
• KERN A, KANHAI W, FROHDE R, KARL W, BADER A: BAY 12–8039 a new 8-methoxyquinolone: metabolism in rat, monkey and man. 36th Interscience Conference on Antimi-crobial Agents & ChemotherapyNew Orleans (1996). F023.
   Google Scholar
• KIM YK, CHOI H, KIM SH et al.: Synthesis and antibacte-rial activities of LB 20304 a new fluoronaphtyridone antibiotic containing novel oxime fimctionalized pyr-rolidine. 35th Interscience Conference on Antimicrobial Agents & Chemotherapy San Francisco (1995). F204.
   Google Scholar
• KITANI H, KUNODA T, MORIGUCHI A et al.: Novel 7-sub-stituted-fluoroquinolones as potent antibacterial agents synthesis and structure-activity relationships. 35th Interscience Conference on Antimicrobial Agents & Chemotherapy San Francisco (1995). F190.
   Google Scholar
• KUBITZA D, STASSWINGENDEN W, KUHLMANN J: BAY 12–8039 a new 8-methoxyquinolone: safety, toler-ability and steady-state pharmacokinetics in healthy male volunteers. 36th Intel-science Conference on Antimi-crobial Agents & Chemotherapy New Orleans (1996). F025.
   Google Scholar
• MAEJIMA T, SENDA H, IWATANI W et al: Potent antibac-terial activity of S-32730 a new fluoroquinolone against Gram-positive bacteria including quinolone-resistant MRSA. 35th Intel-science Conference on Antimicrobial Agents & Chemotherapy San Francisco (1995). F189.
   Google Scholar
• MURATA M, TAKAHARA E, NAGATA O, KATO H, TAMAI I,TSUJI A: Carrier-mediated tissue distribution and phar-macokinetics of HSR-903 a new quinolone. 35th Inter-science Conference on Antimicrobial Agents & Chemotherapy San Francisco (1995). F203.
   Google Scholar
• NISHINO T, TAKAHASHI Y, OTSUKI M: In vitroand in vivoantibacterial activity of HSR-903, a new quinolone. 36th Interscience Conference on Antimicrobial Agents & Chemo-therapy New Orleans (1996). F059.
   Google Scholar
• OH JI, AHN MJ, PAEK KS et al.: In vitro and in vivo antibacterial activities of LB 20304 a new fluoro-naphtyridone. 35th Interscience Conference on Antimicro-bial Agents & Chemotherapy San Francisco (1995). F205.
   Google Scholar
• OKEZAKI E, WATANABE Y, HIROSE T, YOSHIDA T, AOKI Y, KATO H: Antibacterial activity of HSR-903, a new quinolone. 35th Interscience Conference on Antimicrobial Agents & Chemotherapy San Francisco (1995). F202.
   Google Scholar
• PETERSEN U, BREMM KD, DALHOFF A et al: Synthesis and in vitro activity of BAY 12–8039 a new 8-methoxy qui-nolone. 36th Interscience Conference on Antimicrobial Agents & Chemotherapy, New Orleans (1996). F001.
   Google Scholar
• ROBLIN PM, HAMMERSCHLAG MR: Activity of BAY 12–8039 a new 8-methoxyquinolones against Chiamycffa pneumoniae. 36th Interscience Conference on Antimicro-bial Agents & Chemotherapy New Orleans (1996). F011.
   Google Scholar
• RUCKDESCHEL G, LOB S, DALHOFF A: In vitro activity of a new 8-methoxyquinolone, BAY 12–8039 against Le-gionella spp in comparison to ciprofloxacin, erythro-mycin and rifampicin. 36th Interscience Conference on Antimicrobial Agents & Chemotherapy New Orleans (1996). F007.
   Google Scholar
• SEIFERT HM, WEINER K, DOMDEY-BETTE A et al.: BAY12-8039 a new 8-methoxyquinolone: pharmacokinetics in rats and monkeys. 36th Interscience Conference on Antimicrobial Agents & Chemotherapy New Orleans (1996). F019.
   Google Scholar
• SEIFERT HM, DOMDEY-BETTE A, HENNINGER K et al: BAY 12–8039 a new 8-methoxyquinolone: comparison of pharmacokinetics in different mammalian species. 36th Interscience Conference on Antimicrobial Agents & Chemo-therapy New Orleans (1996). F020.
   Google Scholar
• VISALLI M, JACOBS MR, APPELBAUM PC: Antipneumococ-cal activity of BAY 12–8039 a new 8-methoxy quinolone compared to three other quinolones and five I3-lactams. 36th Interscience Conference on Antimicrobial Agents & Chemotherapy New Orleans (1996). F006.
   Google Scholar
• VOHR HW, WASINSKA-KEMPKA G, AHR HJ: Studies on the phototoxic potential of a new 8-methoxyquinolone: BAY 12–8039. 36th Interscience Conference on Antimicrobial Agents & Chemotherapy New Orleans (1996). F021.
   Google Scholar
• WISE R, ANDREWS JM, BRENWALD N: In vitro activity of anew 8-methoxyquinolone BAY 12–8039 in comparison with other fluoroquinolones and I3-lactams against re-cent isolates and Chlamydia. 36th Interscience Conference on Antimicrobial Agents & Chemotherapy New Orleans (1996). F010.
   Google Scholar
• YOKOYAMA Y, MORIMOTO M, IWAO E etal.: Y 688, a newfluoroquinolone with high activity against quinolone resistant Gram-positive bacteria. 35th Intel-science Con-ference on Antimicrobial Agents & Chemotherapy San Fran-cisco (1995). F191.
   Google Scholar
• YOSHIDA T, KADO N, OKEZAKI E, YASUDA S, KATO H: Synthesis and antibacterial activity of HSR-903 and related compounds. 36th Interscience Conference on An-timicrobial Agents & Chemotherapy New Orleans (1996). F058.
   Google Scholar
• BRYSKIER A, CHANTOT JF: Classification and structure-activity relationships of fluoroquinolones. Drugs (1995) 49\(Suppl. 2):16–28.
   Google Scholar
• MATSUSHIMA T, NIKI Y, MIYASHITA N, NAKAJIMA M: In vitro and in vivo activity of HSR 903, a new oral fluoro-quinolone against Chlamydia. 20th International Con-gress on Chemotherapy Sydney (1997) 52. Abstract 2357.
   Google Scholar
• YOSHIDA T, YAMAMOTO Y, ORITA H et al.: Studies onquinolone antibacterials. V. Synthesis and antibacterial activity of chiral 5 -amino-7 (4 - substituted - 3 - amino - 1 - pyrrolidiny0-6 - fluoro - 1,4 - dihydro - 8 - methyl -4 - oxoquinoline - 3 - carboxylic acid and derivatives. Chem. Pharm. Bull. (1996) 44:1376–1386.
   Google Scholar
• MIZUNO A, UMEMURA K, NAKASHIMA M: Pharmacoki-netics and safety of HSR-903 in healthy volunteers. 36th Interscience Conference on Antimicrobial Agents & Chemo-therapy, New Orleans (1996). F060.
   Google Scholar
• MATSUMOTO F, SAKURAI I, ISHIDA Y, TAKAHASHI T,MORITA M: Effects of milk and green tea on absorption of HSR-903, a new quinolone, in healthy volunteers. 20th International Congress on ChemotherapySydney (1997) 140. Abstract 4247.
   Google Scholar
• NIKI Y, WATANABE S, MATSUSHINA T, SEKINO H, MAT-SUOKA O: Effect of HSR 903, a new quinolone, on serum concentration of theophylline. 20th International Con-gress on Chemotherapy, Sydney (1997) 143. Abstract 4264.
   Google Scholar
• OH JI, PAEK KS, AHN NJ et al.: In vitro and in vivo evaluations of LB 20304 a new fluoronaphtyridone. Antimicrob. Agents Chemother. (1996) 40:1564–1568.
   PubMed Web of Science ®Google Scholar
• MIRELIS B, NAVARRO F, MIRO E, COLL R, XICOTA MA: bt vitro activity of E-4868 a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, oflox-acin and fleroxacin. Drugs Exp. Clin. Res. (1995) 21:129–138.
   PubMedGoogle Scholar
• FRIGOLA J, TORRENS A, CASTRILLO JA et al.: 7-azetid-inylquinolones as antibacterial agents. 2. Synthesis and biological activity of 7 - (2,3 - disubstituted - 1 - azetidiny0-4 - oxoquinoline and - 1,8 naphtyridine carboxylic acids. Properties and structure-activity rela-tionships of quinolones with an azetidine moiety. J. Med. Chem. (1994) 37:4195–4210.
   Google Scholar
• COLL R, GARGALLO-VIOLA D, TUDELA E et al.: Antibacte-rial activity and pharmacokinetics of a few new 7-azetid-inyl fluoroquinolones. Antimicrob. Agents Chemother. (1996) 40:274–277.
   PubMed Web of Science ®Google Scholar
• IMAMORI K, ASAOKA T, MATSUMOTO M et al: In vitroantibacterial activity of FA-103, a new quinolone deriva-tive of C-7 position with 7-perhydrodiazepinone. Jpn. I. Antibiot. (1995) 48:1891–1898.
   PubMedGoogle Scholar
• IMAMORI K, ASAOKA T, MATSUMOTO M et al.: In vitro and in vivo antibacterial activities of a new quinolone derivative, FD 501. Jpn. j Antibiot. (1996) 49:264–272.
   PubMedGoogle Scholar
• FUJITA M, EGAWA H, KATAOKA M et al.: Imidazo- and triazoloquinolones as antibacterial agents. Synthesis and structure-activity relationships. Chem. Pharm. (1995) 43:2123–2132.
   Google Scholar
• FUJITA M, EGAWA H, MIYAMOTO T, NAKANO J, MATSU-MOTO JI: 5-alkoxyimidazoquinolones as potential an-tibacterial agents. Synthesis and structure-activity relationships. Chem. Pharm. Bull. (1996) 44:987–990.
   PubMed Web of Science ®Google Scholar
• TSUJI K, TSUBOUCHI H, ISHIKAWA H: Synthesis and antibacterial activities of optically active substituted 1,2 - dihydro -6 - oxo - 611- pyrrolo [3, 2, 1-1(1] quinolone - 5 - carboxylic acids. Chem. Pharm. Bull. (1995) 43:1678–1682.
   PubMed Web of Science ®Google Scholar
• COOPER CS, TUFANO MD, DONNER PK, CHU DTW: The synthesis and in vitro antibacterial activity of confor-mationally restricted quinolone antibacterial agents. Bioorg. Med. Chem. (1996) 4:1307–1315.
   PubMed Web of Science ®Google Scholar
• DOBIAS J: N-succinimidyl ester of ofloxacin - a novel prodrug. Pharmazie (1995) 50:563.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO J, MIYAMOTO T, MINAMIDA A et al.: Pyri- done carboxylic acid as antibacterial agents. 2. Synthe-sis and structure-activity relationships of 1, 6, 7, trisubstituted 1,4 - dihydro - 4 - oxo - 1,8 - naphtyridine - 3 - carboxylic acids, including enoxacin, a new antibac-terial agent. 1 Med. Chem. (1984) 27:292–301.
   Google Scholar
• CECCHETTI V, CLEMENTI S, CRUCIANI G et al.: 6-amino- quinolones: a new class of quinolone antibacterials. J. Med. Chem. (1995) 38:973–982.
   PubMedGoogle Scholar
• CECCHETTI V, FRAVOLINI A, LORENZINI MC et al.: Studies on 6-aminoquinolones: synthesis and antibacterial evaluation of 6-amino-8-methylquinolones. I. Med. Chem. (1996) 39:436–445.
   PubMed Web of Science ®Google Scholar
• SKINNER PS, FURNEY SK, KLEINERT DA, ORME IM: Com-parison of activities of fluoroquinolones in murine macrophages infected with Mycobacterium tuberculo-sis. Antimicrob. Agents Chemother. (1995) 39:750–753.
   PubMed Web of Science ®Google Scholar
• RENAU TE, GAGE JW, DEVER JA et al: Structure -activity relationships of quinolone agents against mycobacte-ria: effect of structural modifications at the 8 position. Antimicrob. Agents Chemother. (1996) 40:2363–2368.
   PubMed Web of Science ®Google Scholar
• RENAU TE, SANCHEZ JP, GAGE JW et al: Structure- activity relationships of the quinolone antibacterials against mycobacteria: effect of structural changes at N-1 and C-7. J. Med. Chem. (1996) 39:729–735.
   PubMed Web of Science ®Google Scholar
• RENAU TE, SANCHEZ JP, SHAPIRO MA et al.: Effect of lipophilicity at N-1 on activity of fluoroquinolones against mycobacteria. J. Med. Chem. (1995) 38:2974–2977.
   PubMed Web of Science ®Google Scholar
• CAEKENBERGHE DV: Comparative in vitro activities of ten fluoroquinolones and fusidic acid. J. Antimicrob. Chemother. (1990) 38:381–386.
   Google Scholar
• YOUNG LS, BERLIN OGW, INDERLIED CB: Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria. Am. J. Med. (1987) 82 (Suppl. 4A) : 23–26.
   Google Scholar
• HAEMERS A, LEYSEN DC, BOLLAERT W, ZHANG M, PAT-TYN SR: Influence of N-substitution on antimycobacte-rial activity of ciprofloxacin. Antimicrob. Agents Chemother. (1990) 34:496–497.
   PubMed Web of Science ®Google Scholar
• TOMIOKA H, SAITO H, SATO K: Comparative antimyco-bacterial activity of the newly synthesized quinolone AM 1155, sparfloxacin and ofloxacin. Antimicrob. Agents Chemother. (1993) 37:1259–1263.
   PubMed Web of Science ®Google Scholar
• REUMAN M, DAUM SJ, SINGH B et al.: Synthesis and antibacterial activity of some novel 1-substituted 1,4-di-hydro-4-oxo-7-pyridinyl - 3 - quinoline carboxylic ac-ids. Potent antistaphylococcal agents. J. Med. Chem. (1995) 38:2531–2540.
   Web of Science ®Google Scholar
• KLOPMAN G, WANG S, JACOBS MR, ELLNER JJ: Anti Mycobacterium avium activity of quinolones: struc-tures-activity relationship studies. Antimicrob. Agents Chemother. (1993) 37:1807–1815.
   PubMed Web of Science ®Google Scholar
• KLOPMAN G, WANG S, JACOBS MR et al.: Anti Mycobac-terium avium activity of quinolones: in vitro activities. Antimicrob. Agents Chemother. (1993) 37:1799–1806.
   PubMed Web of Science ®Google Scholar
• KLOPMAN G, LI JY, WANG S et al.: In vitro anti-Mycobac-terium avium activities of quinolones: predicted active structures and mechanistic considerations. Antimicrob. Agents Chemother. (1994) 38:1774–1782.
   Google Scholar